Brief: Ascelia Pharma Q1 Operating Loss Widens To SEK 13.9 Mln

Ascelia Pharma AB

08/11/2019 07:07

Nov 8 (Reuters) - Ascelia Pharma AB  ACELP.ST :
    * PREPARATIONS FOR PHASE III STUDY WITH MANGORAL ®  ON TRACK
    * Q1 2019/2020 OPERATING RESULT OF SEK -13.9M (SEK -3.9M)
    * Q1 CASH FLOW FROM OPERATIONS OF SEK -20.1M (SEK -3.8M)

Source text for Eikon:  ID:nWkr8CrKR6 
Further company coverage:  ACELP.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))